Navigation Links
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Osiris Therapeutics, Inc.
Date:10/22/2013

NEW YORK, Oct. 22, 2013 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Osiris Therapeutics, Inc. ("Osiris" or the "Company") (NasdaqGM: OSIR). Such investors are advised to contact Peretz Bronstein or his Investor Relations coordinator Eitan Kimelman at info@bgandg.com or 212-697-6484.

The investigation concerns whether Osiris and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.  On October 21, 2013, shares of Osiris fell $2.98 or 17.01% to close at $14.51 after the company said the Food and Drug Administration will treat its wound care product Grafix as a drug.  The company said Grafix will remain on the market, but it will file a Biologics License Application to expand the drug's approval.  According to the October 20, 2013 regulatory filing the Company will resolve concerns the FDA raised in an untitled letter dated September 26, 2013 and that Osiris and the FDA reached a resolution to these concerns on September 30, 2013.

If you are aware of any facts relating to this investigation, or purchased shares of Osiris, you can assist this investigation by contacting Peretz Bronstein or his Investor Relations Coordinator Eitan Kimelman of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email info@bgandg.com.  Those who inquire by e-mail are encouraged to include their mailing address, email and telephone number.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration.  Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Eitan Kimelman 212-697-6484
info@bgandg.com


'/>"/>
SOURCE Bronstein, Gewirtz & Grossman, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc.
2. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Spectrum Pharmaceuticals, Inc.
3. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Impax Laboratories Inc.
4. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Amylin Pharmaceuticals, Inc.
5. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Alexza Pharmaceuticals Inc.
6. Frost & Sullivan Examines the Future of On-Demand Mobile Personal Health Records
7. Frost & Sullivan Unveils Future Opportunities for the Tissue Diagnostics Market
8. mHealth Apps & Solutions Market - Global Trends & Forecast to 2018
9. Singh & Associates and Sughrue Mion PLLC in association with Lex WITNESS present The IPR Exchange - An Indo US IPR Summit
10. PTC Therapeutics to Showcase Breadth of Pipeline at Upcoming R&D Day
11. Cornerstone Therapeutics Inc. Stockholders Seeking More Money Regarding the Proposed Buyout by Chiesi Farmaceutici S.P.A. Encouraged to Contact Lawyers at Deans & Lyons
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2019)... ... November 06, 2019 , ... Big Buzz continues to build upon ... into healthcare and medical technology. The agency - which primarily serves the biosciences, specialty ... members spoke at prominent events nationwide. , In June, Big Buzz was named a ...
(Date:11/6/2019)... ... November 06, 2019 , ... James M. Barthel, CEO ... most lucrative way to transform their range lead into profit by giving the range ... quickly receive a check for the absolute highest value for their lead. No one ...
(Date:11/6/2019)... N.Y. (PRWEB) , ... November 06, 2019 , ... ... CEO of LiveOnNY, presented Northern Westchester Hospital (NWH) President and CEO, Joel Seligman, ... Seligman was honored for his commitment to raising awareness, providing education and registering ...
Breaking Medicine Technology:
(Date:11/12/2019)... Calif. (PRWEB) , ... November 12, 2019 , ... ... the most complete business management solution for physical therapy and rehabilitation operators throughout ... patient engagement technology with customers in 102 countries, today announces a joint venture ...
(Date:11/11/2019)... ... November 11, 2019 , ... ... to dental groups in the United States, today announced the grand opening of ... CA. , Patients will enjoy convenient hours, comfortable offices and full-service care at ...
(Date:11/11/2019)... ... 2019 , ... Artemis, the leading enterprise Cultivation ... adoption of compliance technology in the wake of the November 3 voluntary ... in the United States and Canada due to potential contamination with Listeria monocytogenes. ...
(Date:11/9/2019)... ... 2019 , ... Pennsylvania College of Health Sciences, the area’s ... the fourth quarter of the 2018-2019 academic year, the school’s NCLEX scores continue ... College’s annual pass rate for the 2018-2019 academic year was 95.02%, maintaining the ...
(Date:11/7/2019)... ... 06, 2019 , ... An October 13 article on Yahoo News ... the article, while no U.S. state had an obesity rate above 15 percent in ... The article cites quite a few reasons for this rise, including eating out more ...
Breaking Medicine News(10 mins):